{'fraction_non_alphanumeric': 0.033932135728542916, 'fraction_numerical': 0.023952095808383235, 'mean_word_length': 5.048192771084337, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
RSM Coloproctology Section

Methods A consecutive series of patients with complex perianal Crohn’s Disease between January 2003 and June 2008 were included. Acute sepsis was treated with antibiotics, incision and drainage (I&D), and seton insertion. Infliximab was infused at 5 mg/kg at 0, 2, and 6 weeks. MR scans done prior to IFX &Setons were empirically removed after IFX second cycle. Endpoints were complete, partial or no response documented at outpatient follow up &adverse reactions recorded.